AMGN - Amgen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
23,395,000
23,747,000
22,849,000
22,991,000
Cost of Revenue
4,199,000
4,101,000
4,069,000
4,162,000
Gross Profit
19,196,000
19,646,000
18,780,000
18,829,000
Operating Expenses
Research Development
3,986,000
3,737,000
3,562,000
3,840,000
Selling General and Administrative
5,196,000
5,332,000
4,870,000
5,062,000
Total Operating Expenses
9,188,000
9,383,000
8,807,000
9,035,000
Operating Income or Loss
10,008,000
10,263,000
9,973,000
9,794,000
Interest Expense
1,340,000
1,392,000
1,304,000
1,260,000
Total Other Income/Expenses Net
-
-
-
0
Income Before Tax
9,340,000
9,545,000
9,597,000
9,163,000
Income Tax Expense
1,273,000
1,151,000
7,618,000
1,441,000
Income from Continuing Operations
8,067,000
8,394,000
1,979,000
7,722,000
Net Income
8,067,000
8,394,000
1,979,000
7,722,000
Net Income available to common shareholders
8,067,000
8,394,000
1,979,000
7,722,000
Reported EPS
Basic
-
12.70
2.71
10.32
Diluted
-
12.62
2.69
10.24
Weighted average shares outstanding
Basic
-
661,000
731,000
748,000
Diluted
-
665,000
735,000
754,000
EBITDA
-
12,883,000
12,856,000
12,528,000